← SynDRA
TERUTROBAN
SynDRA canonical compound SYN0033239 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | TBXA2R |
|---|
| Mechanism of action | prostanoid receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- TBXA2R ANTAGONIST
- Thromboxane A2 receptor antagonist
- prostanoid receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADGRF1
- ADRA2A
- TDG
- SMUG1
- S1PR1
- OGG1
- NTHL1
- NEIL2
- NEIL1
- MUTYH
- MPG
- MBD4
- HDAC6
- GPR35
- GPR119
- GLP1R
- FPR2
- FFAR4
- CX3CR1
- C5AR1
- APLNR
- AGTR1
- ADRB2
- UNG
Cross-references
Synonyms
- S18886
- Triplion
- triplion
- S-18886
- A6WX9391D8
- terutrobanum
- RefChem:188312
- DTXCID201526877
- S-18204
- Terutroban [INN]
- UNII-A6WX9391D8
- TERUTROBAN [WHO-DD]
- GTPL6073
- orb1301736
- SCHEMBL1896773
- SCHEMBL29378918
- GLXC-03557
- EX-A6004
- BDBM50026753
- AKOS025293445
- CS-4806
- BS-16000
- BT163710
- DA-57595
- HY-16991
- T5505
- D83664
- BRD-K43975632-001-01-1
- S 18886
- تيروتروبان
- Terutroban sodium
- KP3SN6UT5P
- S-18886 sodium
- SCHEMBL29522952
- 1-Naphthalenepropanoic acid, 6-(((4-chlorophenyl)sulfonyl)amino)-5,6,7,8-tetrahydro-2-methyl-, monosodium salt,
- GLXC-02908
- Terutroban sodium salt
- DB-107908
Look up TERUTROBAN in the interactive SynDRA portal →